Launched in summer 2020, the PHOSP-COVID study aims to understand and improve long-term health outcomes for patients who have been in hospital with confirmed or suspected COVID-19.
The latest results from this study, posted as a preprint, looks at the symptoms and recovery of adults who had been hospitalised with COVID-19 five and 12 months after hospital discharge. The study assesses the participants’ most common ongoing symptoms and how many people felt fully recovered after a year. It also investigates the possibility of several distinct groups among the participants based on the severity of physical, mental and cognitive impairments experienced at five months and looks at the blood profiles across these groups.
Please note this data is a preprint, so it is early work that has not yet been through peer-review and is not published in a journal.
Journalists dialled in to this briefing to hear the authors present their work and answer any questions.
Prof Chris Brightling, Professor of Respiratory Medicine, University of Leicester
Dr Rachael Evans, NIHR Clinical Scientist, University of Leicester
Prof Louise Wain, GSK/British Lung Foundation Chair in Respiratory Research, University of Leicester
Prof John Geddes, Head of Department of Psychiatry at the University of Oxford and Director of the Oxford Health Biomedical Research Centre
Dr Nazir Lone, Senior Clinical Lecturer in Critical Care at the University of Edinburgh and Consultant in Critical Care at the Royal Infirmary of Edinburgh